摘要 |
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein A, D, E, G, J, X, Y, Z R<SUP>6</SUP>, R<SUP>7 </SUP>and R<SUP>8 </SUP>are as defined herein. Also provided are methods of using the compounds for treating diseases mediated by a P2X<SUB>3 </SUB>and/or a P2X<SUB>2/3 </SUB>receptor antagonist and methods of making the compounds.
|